News articles about Varian Medical Systems (NYSE:VAR) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Varian Medical Systems earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave media headlines about the medical equipment provider an impact score of 45.6458535329806 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
These are some of the media headlines that may have impacted Accern Sentiment’s scoring:
- Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 1,089 Shares of Stock (americanbankingnews.com)
- Varian Medical Systems (VAR) Scheduled to Post Quarterly Earnings on Tuesday (americanbankingnews.com)
- Varian Medical Systems (VAR): Is This Stock Making The Grade? (nismagazine.com)
- Varian Medical Systems (VAR) Releases FY18 Earnings Guidance (americanbankingnews.com)
- Insider Selling: Varian Medical Systems, Inc. (VAR) SVP Sells 7,991 Shares of Stock (americanbankingnews.com)
Shares of Varian Medical Systems (NYSE:VAR) traded down $0.41 during trading on Tuesday, reaching $108.08. The company had a trading volume of 997,513 shares, compared to its average volume of 780,090. Varian Medical Systems has a one year low of $76.94 and a one year high of $114.09. The company has a market cap of $9,900.00, a PE ratio of 39.16, a P/E/G ratio of 3.30 and a beta of 0.68.
Several equities analysts have recently weighed in on VAR shares. Zacks Investment Research cut Varian Medical Systems from a “hold” rating to a “sell” rating in a report on Friday, October 27th. Citigroup increased their price target on Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a report on Monday, October 30th. Evercore ISI started coverage on Varian Medical Systems in a report on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 price target on the stock. BTIG Research reissued a “hold” rating on shares of Varian Medical Systems in a report on Sunday, October 29th. Finally, Royal Bank of Canada set a $105.00 price target on Varian Medical Systems and gave the company a “hold” rating in a report on Thursday, November 30th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company’s stock. Varian Medical Systems currently has a consensus rating of “Hold” and an average price target of $100.44.
In related news, EVP Kolleen T. Kennedy sold 931 shares of the firm’s stock in a transaction on Wednesday, October 18th. The stock was sold at an average price of $105.00, for a total value of $97,755.00. Following the transaction, the executive vice president now directly owns 27,531 shares of the company’s stock, valued at approximately $2,890,755. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Kolleen T. Kennedy sold 2,018 shares of the firm’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $111.97, for a total value of $225,955.46. Following the sale, the executive vice president now directly owns 27,749 shares in the company, valued at $3,107,055.53. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 112,816 shares of company stock worth $12,510,334. 0.78% of the stock is owned by insiders.
TRADEMARK VIOLATION WARNING: “Varian Medical Systems (VAR) Earns News Impact Score of 0.19” was reported by BBNS and is owned by of BBNS. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://baseballnewssource.com/markets/varian-medical-systems-var-receiving-somewhat-positive-news-coverage-accern-reports/1821436.html.
About Varian Medical Systems
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.